Association of cellular localization of glycogen synthase kinase 3beta in the digestive tract with cancer development

Hiroshi Hirakawa1, Toshiyuki Nakayama, Kenichiro Shibata

  • 1Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan. h-hira@nagasaki-u.ac.jpc

Oncology Reports
|July 30, 2009
PubMed

Insights

Glycogen synthase kinase 3beta (GSK-3beta) is crucial for normal colon epithelium structure. Its altered localization in cancer tissues suggests a role in tumor development and lymphatic invasion.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Glycogen synthase kinase 3beta (GSK-3beta) is a key kinase in cellular signaling pathways.
  • Previous research identified polarized apical membrane localization of GSK-3beta in normal colon epithelium.

Purpose of the Study:

  • To investigate the role and localization of GSK-3beta in stomach and colorectal cancer.
  • To understand the association of GSK-3beta localization with cancer development and invasion.

Main Methods:

  • Immunohistochemical analysis of GSK-3beta and ZO-1 expression in normal, tubular adenocarcinoma, and signet-ring cell carcinoma tissues.
  • Comparative analysis of protein localization patterns between normal and cancerous tissues.

Main Results:

  • GSK-3beta and ZO-1 showed similar apical localization in normal epithelium and tubular adenocarcinoma.
  • Altered GSK-3beta and ZO-1 localization at the invasive front of tubular adenocarcinoma correlated with lymphatic invasion.
  • Signet-ring cell carcinoma exhibited reduced expression and dot-like GSK-3beta localization.

Conclusions:

  • GSK-3beta is implicated in glandular structure formation.
  • Aberrant, non-apical GSK-3beta localization in tubular adenocarcinoma is associated with cancer progression.
  • GSK-3beta's altered localization may serve as a biomarker for cancer invasiveness.